Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-25 @ 3:56 AM
NCT ID:
NCT00119002
Eligibility Criteria:
Inclusion Criteria:
* First attack of wheezing within 7 days of onset
* Age 2 months through 11 months (less than 12 months)
* Disease of at least moderate severity (RDAI score greater than or equal to 6)
Exclusion Criteria:
* Prior adverse reaction to dexamethasone
* Known heart or lung disease
* Premature birth prior to 36 weeks' gestation
* History of prior asthma or bronchodilator use
* Immune suppression or deficiency
* Trisomy 21
* Critical or life-threatening complications of bronchiolitis
* Treatment with corticosteroids within 14 days
* Known active chickenpox
* Exposure to chickenpox within 21 days
* Child sent to ED for automatic admission
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Months
Maximum Age:
11 Months
Study:
NCT00119002
Study Brief:
Protocol Section:
NCT00119002